UGGT1 Antibodies

Santa Cruz Biotechnology provides a broad selection of UGGT1 monoclonal antibodies for research focused on understanding UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1). UGGT1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UGGT1 plays a critical role in protein quality control within the endoplasmic reticulum by ensuring proper folding of glycoproteins. UDP-glucose:glycoprotein glucosyltransferase 1 is essential for maintaining cellular homeostasis and has been linked to various diseases when protein misfolding occurs. Research into UGGT1 function continues to reveal new insights about mechanisms of protein misfolding and associated pathologies. Investigating UDP-glucose:glycoprotein glucosyltransferase 1 advances understanding of fundamental cellular processes and disease mechanisms. Researchers worldwide rely on UGGT1 monoclonal antibodies to explore protein quality control pathways and cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies enable scientists to make meaningful contributions to protein folding research and advance our understanding of disease mechanisms.